Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy
2011

HIV Prevention in French Prisons: A Study on Access and Guidelines

Sample size: 171 publication 10 minutes Evidence: moderate

Author Information

Author(s): Michel Laurent, Marie Jauffret-Roustide, Jerôme Blanche, Olivier Maguet, Christine Calderon, Julien Cohen, Patrizia M Carrieri

Primary Institution: Health and Medical Research National Institute, Research Unit 669, Paris, France

Hypothesis

How well do French prisons adhere to national and WHO guidelines for HIV prevention?

Conclusion

There is a significant gap between HIV prevention policies and their actual implementation in French prisons.

Supporting Evidence

  • 66% of the 171 prisons responded to the survey.
  • Median adherence scores were low: 4.5 for national guidelines and 2.5 for WHO guidelines.
  • Only 27% of prisons adhered to opioid substitution treatment guidelines.

Takeaway

This study found that prisoners in France have very limited access to HIV prevention tools, even though there are guidelines meant to help them.

Methodology

A nationwide survey was conducted using questionnaires and phone interviews with heads of medical and psychiatric units in French prisons.

Potential Biases

Social desirability bias may affect the accuracy of reported adherence to guidelines.

Limitations

Self-reports may be biased, and the study may overestimate adherence rates due to the selection of more compliant prisons.

Participant Demographics

The study included 171 prisons, with 113 responding, covering 74% of the French prison population.

Digital Object Identifier (DOI)

10.1186/1471-2458-11-400

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication